Back to today’s briefing

Story perspectives

Gonorrhea Resistance Soars: Tetracycline Threatens Treatment Options

7/12/2025

43 8

Summary

Story summary

A recent genomic analysis of gonorrhea isolates in the US uncovers a troubling surge in tetracycline resistance, with the tetM gene prevalence skyrocketing from 10% in 2020 to over 30% in 2024. This alarming trend, tied to the rising use of doxycycline for chlamydia treatment, raises urgent concerns about the emergence of untreatable gonorrhea strains and the critical need for improved surveillance.

1 of 1

Story summary

A recent genomic analysis of gonorrhea isolates in the US uncovers a troubling surge in tetracycline resistance, with the tetM gene prevalence skyrocketing from 10% in 2020 to over 30% in 2024. This alarming trend, tied to the rising use of doxycycline for chlamydia treatment, raises urgent concerns about the emergence of untreatable gonorrhea strains and the critical need for improved surveillance.